Autism is a lifelong developmental disability that affects how a person communicates with, and relates to, other people. It also affects how they make sense of the world around them. Autism is a spectrum condition, which means that, while all people with autism share certain difficulties, their condition will affect them in different ways. Some people with autism are able to live relatively independent lives but others may have accompanying learning disabilities and need a lifetime of specialist support. People with autism may also experience over or under sensitivity to sounds, touch, tastes, smells, light or colors.
Two common consistent findings are associated in children with this disorder are diminished oxygenation in specific areas of the brain and a chronic immunologically mediated inflammatory condition in the gut.
Studies have shown that autistic patients who have been treated through stem cell therapy when they were younger have shown the most significant improvements. Their focus improved, as well as emotional contact, with a considerable decrease in the frequency of erratic mood swings. Mesenchymal stem cells can regulate the immune system. Stem cells are thought to be able to reverse inflammatory conditions and is currently in the final stages of clinical trials in the US for Crohn’s disease, a condition resembling the gut inflammation in autistic children.
Adult mesenchymal stem cells are used to treat children with Autism Spectrum Disorder (ASD). Because the treatment is usually administered to children, they will undergo anesthesia by an experienced anesthesiologist that specializes in children. Depending upon the age and physical size of the patient there may be a combination of the administration methods used.
Typically, the stem cells will be given through an IV, lumbar puncture and/or intranasal implantation. Both intrathecal (lumbar puncture) and intranasal administrations allow the stem cells to bypass the blood-brain barrier and migrate throughout the central nervous system.
Our goal and main concern at SCHI is finding the best treatment possible for autism. With this in mind, we take follow-up care very seriously and will be contacting you to ensure that your child is progressing as expected. Regular follow up enables us to evaluate and improve our autism treatment protocols based on the observed outcomes of all of our patients. Our medical staff will contact you every other month to monitor the progress of the treatment received by your child.
World J Stem Cells. 2014 Apr 26;6(2):173-8. doi: 10.4252/wjsc.v6.i2.173
Siniscalco D1, Bradstreet JJ1, Sych N1, Antonucci N1.
2015 Mar;84(3):169-77. doi: 10.1016/j.mehy.2014.12.016. Epub 2014 Dec 30. Gesundheit B1, Ashwood P2, Keating A3, Naor D4, Melamed M5, Rosenzweig JP6.
World J Stem Cells. 2014 Apr 26;6(2):111-9. doi: 10.4252/wjsc.v6.i2.111. Ng TK1, Fortino VR1, Pelaez D1, Cheung HS1.